Insider · CIK 0001880371
David Molero Santos
Files at DXPE (DXP ENTERPRISES INC). First filing Jun 11, 2025, latest Jun 15, 2026.
In brief
David Molero Santos files SEC Form 4 as officer at DXPE (DXP ENTERPRISES INC). Since Jun 11, 2025, David Molero Santos has reported 0 open-market buys worth $0 and 2 open-market sells worth $241k, the latest filed on Jun 15, 2026.
A track record needs three past buys with six months of prices behind them; David Molero Santos has 0, so none is measured yet.
The newest scored trade: sold $189k of DXPE on Jun 15, 2026, filed Jun 15, 2026, scored 40 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $189k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DXPE: DXP ENTERPRISES INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | DXP ENTERPRISES INC | $189k 1,100 shares | -19% | +115% from low-7% from high | |
| 35Weak | DXP ENTERPRISES INC | $53k 650 shares | -11% | +67% from low-25% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 15, 2026 | DXPE DXP ENTERPRISES INC | 1,100 0.01% of outstanding | $188k | Jun 15, 2026 | none |
| Jun 6, 2025 | DXPE DXP ENTERPRISES INC | 650 0.00% of outstanding | $53k | Jun 6, 2025 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | DXPE DXP ENTERPRISES INC | FTax withholding DXP Common Stock | -194 | $144.20 | $28k | 5,649 | Jun 15, 2026 |
| Jun 15, 2026 | DXPE DXP ENTERPRISES INC | SOpen-market sale DXP Common Stock | -1,100 | $171.50 | $189k | 4,549 | Jun 15, 2026 |
| Apr 8, 2026 | DXPE DXP ENTERPRISES INC | FTax withholding DXP Common Stock | -603 | $138.04 | $83k | 5,843 | Apr 10, 2026 |
| Mar 3, 2026 | DXPE DXP ENTERPRISES INC | AGrant or award DXP Common Stock | +1,192 | $138.47 | $165k | 6,446 | Mar 4, 2026 |
| Jun 11, 2025 | DXPE DXP ENTERPRISES INC | SOpen-market sale DXP Common Stock | -650 | $81.30 | $53k | 5,076 | Jun 11, 2025 |
| Jun 4, 2025 | DXPE DXP ENTERPRISES INC | FTax withholding DXP Common Stock | -185 | $83.60 | $15k | 5,726 | Jun 5, 2025 |
| Apr 2, 2025 | DXPE DXP ENTERPRISES INC | FTax withholding DXP Common Stock | -335 | $82.88 | $28k | 5,911 | Apr 4, 2025 |
| Mar 26, 2025 | DXPE DXP ENTERPRISES INC | AGrant or award DXP Common Stock | +2,121 | $88.40 | $187k | 6,246 | Mar 27, 2025 |
| Mar 28, 2024 | DXPE DXP ENTERPRISES INC | AGrant or award DXP Common Stock | +2,513 | $0.00 | $0 | 4,089 | Apr 2, 2024 |
Questions about David Molero Santos
Answered from the filings on this page, as of the latest one.
Is David Molero Santos buying or selling?
In the last 12 months David Molero Santos reported 0 open-market buys worth $0 and 1 open-market sell worth $189k on SEC Form 4; the latest was sold $189k of DXPE on Jun 15, 2026. Grants, option exercises and tax withholding are not counted.
How did David Molero Santos's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Molero Santos has 0.
Where does David Molero Santos file Form 4?
David Molero Santos has filed Form 4 at DXPE (DXP ENTERPRISES INC) as CHIEF ACCOUNTING OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.